Mole count and genetics strongly impact mole-linked melanoma risk, while sun exposure affects both melanoma types equally.
Oncology
Advertisement
Researchers identified 4 genes tied to propionate metabolism to predict head and neck cancer risk and survival.
NF1-mutant melanoma may respond to EGFR inhibitors, offering hope for patients resistant to immunotherapy.
Forty-seven genes were linked to patient survival.
Lower education level was linked to reduced access to mutational testing and clinical trials.
The prospective case series demonstrates the efficacy of the combination in second- and later-line treatment.
Targeted therapies directed toward tumor genotype should be considered in addition to standard-of-care regimens.
New biomarker 2,3,6-trichlorobenzaldehyde shows 95% accuracy in blood tests for early cervical cancer and CIN detection.
Menstrual blood HPV testing shows 100% match with cervical smears—non-invasive, accurate, and preferred by most women.
This was an unexpected finding because mature TLS are typically rare in poorly immunogenic HPV-negative HNSCC.
Tumor mutations were even detected in early-stage disease.
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.